Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Aptevo Therapeutics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 19 | 13 | −6 |
| Shares | 1.28M | 48.5K | −1.23M (−96.2%) |
| Value | $231.1K | $208.7K | −$22.5K (−9.7%) |
New holders (4)
Institutions that held Aptevo Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diadema Partners LP | 4,050 | $17.5K | 0.02% |
| SBI Securities Co., Ltd. | 131 | $565 | 0.00% |
| Center for Financial Planning, Inc. | 5 | $22 | 0.00% |
| Danske Bank A/S | 1 | $4 | 0.00% |
Sold out (10)
Institutions that held Aptevo Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Hudson Bay Capital Management LP | 935,552 | $168.2K |
| Citadel Advisors LLC | 111,632 | $20.1K |
| Geode Capital Management, LLC | 43,684 | $7.85K |
| Renaissance Technologies LLC | 36,575 | $6.58K |
| Two Sigma Securities, LLC | 28,020 | $5.04K |
| Jane Street Group, LLC | 17,218 | $3.10K |
| Two Sigma Investments, LP | 14,195 | $2.55K |
| Wells Fargo & Company | 33 | $6 |
| The PNC Financial Services Group, Inc. | 3 | $1 |
| Truvestments Capital LLC | 2 | $0 |